Market Overview

The apheresis equipment market size was valued at around 2.90 Billion in 2023 and is expected to reach a value of USD 6.35 Billion by 2032, at a CAGR of 9.1% over the forecast period (2024–2032).

Various factors have been the reasons for the growth in the global apheresis equipment market, such as an increased incidence of chronic diseases, improvement in medical technology, and interest in personalized medicine and therapeutic approaches. Some of the conditions treated by apheresis include cancer, autoimmune disease, and hematologic disorders by separating and extracting particular blood components such as plasma, platelets, or red and white blood cells. This is because it is capable of selectively removing poisonous or unnecessary substances from the blood of a patient; hence it has become one of the most used tools in both treatment procedures and investigations.

The increasing incidence of autoimmune diseases and blood disorders mainly fuels the apheresis equipment market. With the growing diseases' incidence, efficient treatments such as therapeutic apheresis have become necessary, so increasing demand is seen with increased illnesses such as myasthenia gravis, multiple sclerosis, and systemic lupus erythematous. Apheresis procedures are very important in haematology, especially for patients with sickle cell disease, leukaemia, and other forms of blood disorders, as it serves as the major tool in management, slowing down disease progression, and especially enhancing quality of life. This requirement for reliable and effective apheresis equipment has triggered research and development expenses, especially from the medical device companies that will enhance machine efficiency, patient safety, and ease of use.

Technological advancement is also a key factor driving the apheresis equipment market. The technology is more accurate and less invasive as automation and artificial intelligence advance with reduced danger and increasing the pace of the apheresis process. For example, innovation in sensors and real-time monitoring capabilities may enable better observation of patients by healthcare providers and amendments in treatment procedures based on responses. This would greatly reduce problems and enhance the outcomes. In addition, modern apheresis technology is more portable and user-friendly, so this method of therapy is accessible in clinics and small hospitals rather than in big hospitals and specialty facilities alone.

The other reason apheresis is increasingly needed as a continuous therapy approach is due to an increase in chronic diseases around the world, especially among the elderly. By removing any excess material such as cholesterol, autoantibodies, or immunological complexes, the apheresis apparatus can manage no communicable diseases like diabetes, heart disease, and chronic kidney disease that are increasingly coming to characterize health systems around the world.

Key Findings:

• Compared with the target 1,068.2 tonnes of plasma, Lifeblood collected 842.4 tonnes during 2022–2023. This comprised 654.6 tonnes of plasma collected via apheresis and 187.8 tonnes of plasma from whole blood. Like in 2021–2022, increasing red blood cell collection and unpredictable attendance by donors significantly impacted 2022–2023 plasma collections, forcing Lifeblood to move at certain times of the year from plasma collection to whole blood donation.

Market Dynamics - Market Drivers

Increasing Prevalence of Autoimmune and Chronic Diseases

• The key growth driver in the global apheresis equipment market is the rising prevalence of autoimmune and chronic diseases. Autoimmune diseases, which include multiple sclerosis, rheumatoid arthritis, and systemic lupus erythematous, along with chronic diseases like diabetes, cardiovascular conditions, and hematologic disorders, are increasingly found everywhere around the world. Most of these diseases require specialized treatments aimed at the removal of harmful substances, alleviation of symptoms, or prevention, in some cases, of further disease progression. Apheresis procedures are increasingly applied in these situations, allowing for the selective removal of blood components, such as autoantibodies, cholesterol, or immune complexes contributing to worsening of the disease. The net result is that demand for apheresis equipment is rising dramatically as healthcare providers look for effective therapeutic approaches to these chronic and autoimmune illnesses.

Technological Advancements in Apheresis Equipment

• Technological improvement of apheresis machines increases market size. Advanced apheresis equipment comprises higher automation and artificial intelligence with advanced sensors that raise accuracy and patient safety. Such developments make for more efficient processes that come with real-time monitoring, thus allowing medical professionals to make immediate improvements contingent upon the reaction observed in a patient. All these developments make apheresis more appealing for all types of clinical application since they reduce the likelihood of complications and maximize effects from the therapy. In addition, easy-to-use equipment that can be easily transported is available to ensure that technology spreads to a wider scope of healthcare facilities other than large hospitals or specialist centres, such as smaller clinics or outpatient departments.

Key Findings:

• In May 2023, to help cell and gene therapy manufacturers improve cell collection processes and advance the commercialisation of therapies, TERUMO BCT, INC. launched its first training program initiative.

Market Opportunities

Growing Demand for Personalized Medicine

• Apheresis equipment holds bright prospects as the need for personalized medicine continues to increase. The highly tailor-made treatments to the different characteristics of each patient, based on individual traits, are increasingly needed as customized medicine becomes the talk of the town in the healthcare industry. Apheresis is the ideal technology for individualized treatment in areas such as immunology, haematology, and oncology since it would enable the extraction or isolation of specific blood components of interest. Thus, the apheresis market is expected to grow because of the trend toward personalized treatment approaches, which are specifically beneficial for complicated diseases in which the conventional treatments are not sufficiently viable.

Expansion of Apheresis Applications in Research and Clinical Trials

• Another critical potentiality concerns an expansion in the use of apheresis in clinical research and investigations. Research and development are better serviced by the ability of apheresis to selectively remove certain parts of blood, mainly in areas such as cancer research, cell-based treatments, and regenerative medicine. Precise separation of blood components has now become more important for scientists with a strive for knowing more and innovating new remedies. This new remedy also falls under apheresis, and so it has scopes in the clinical trials for advancing improvement in efficacy in newly developed medicines, especially in the areas of immunological regulation and cell therapy.

Market Restraining Factors

High Cost of Apheresis Procedures and Equipment

• High cost of apheresis procedures and equipment: One of the major market barriers is that apheresis procedures and equipment are very expensive. For a patient, high-cost apheresis devices and the respective disposables required for each session create a financial burden to him/her as well as to the healthcare provider. Apheresis is more inaccessible because of its costly price often; it hinders the use of the technology, particularly in low- and intermediate-income areas. Such expenses related to maintenance and operation, combined with qualified staff, add to the total costs and prevent widespread use of apheresis in cost-sensitive healthcare settings.

Limited Availability of Skilled Professionals

• Qualified specialists who are required to carry out apheresis treatments are also in short supply. Apheresis is a complex treatment, and therefore only experienced operators with specific knowledge are authorized to manage and control the process. Apheresis treatment alternatives are difficult to develop and maintain in healthcare facilities since there are not enough qualified professionals in most areas. Because untrained operators may imply a higher risk or complications, this shortage of proper individuals does not only limit access to such procedure but also adds up to an impact on the general effectiveness and safety of the treatment.

Segmentation Analysis

The market scope is segmented because of by Product, by Application, by Procedure, By Technology.

By Product

Based on the Product of the market is segmented into Disposable Apheresis Kits, Devices.

The disposable apheresis kits segment has dominated the global market for apheresis equipment. While apheresis devices, because they have a longer lifespan, typically require a one-time purchase followed by periodic maintenance, disposables are required for each apheresis process, representing a huge chunk of dominance in the market. Use disposable kits with tubing, needles, and collecting bags that have to be used and replaced every session, thus triggering an on-going cycle of demand. On account of this constant and high-volume demand, the disposable kits offer a more lucrative niche in the market.

For example, the growing demand for therapeutic apheresis in numerous fields, such as neurology, cancer, and haematology, propels the growth of the disposable kits market. Hospitals and clinics that adhere to stringent infection control policies rely on single-use disposables primarily due to the need to minimize cross-contamination possibility. The demand for these kits has grown with the globalization of apheresis operations and especially with the treatments of autoimmune and chronic diseases. Disposable kits are critical in the apheresis market as they ensure patient safety and that the process is effective. Stringent safety regulations and high turnover rates have served to place the disposable apheresis kits segment with a larger market share than devices.

By Application

Based on the Application of the market is segmented into Renal Diseases, Haematology, Neurology, Others.

The haematology segment has been dominating the global market for apheresis equipment. It is mainly due to the high incidence of haematological illnesses, comprising leukaemia, sickle cell anaemia, lymphoma, and other blood-related conditions that require apheresis as an essential therapeutic or supportive treatment. Apheresis techniques are commonly used in haematology for both therapeutic purposes, such as plateletpheresis for the management of patients with high counts of platelets and red cell exchange for sickle cell disease, and to collect specific blood components for the transfusion of cancer patients receiving chemotherapy. In the management and treatment of some blood disorders, the ability to replace or remove individual blood components selectively is very useful.

Other factors fuelling the persistent demand for apheresis equipment in this market is repeated and frequent apheresis sessions in haematology, particularly with chronic diseases. Thanks to advancement in medical technology, apheresis is now more accessible and effective and has positioned itself as the best alternative treatment for complicated hematologic disorders. The development of sophisticated apheresis procedures that better disease management and improve patient outcomes—particularly in haematology, where tailored and targeted treatments are crucial—further solidifies this segment's supremacy. The haematology category is leading the apheresis equipment market because of the critical role apheresis plays in treating these high-incidence hematologic illnesses.

Regional Snapshots

By region, Insights into the markets in North America, Europe, Asia-Pacific, Latin America and MEA are provided by the study. North America has been the leading force in the global apheresis equipment market owing to an advanced health care infrastructure, a higher prevalence of chronic and autoimmune diseases, as well as higher adoption of innovative medical technologies. Advanced health care systems of the region as well as high healthcare spend allow higher access to apheresis treatments. Research and development investments over time are further propelling advancements in apheresis technology. Haematological and autoimmune disorders, including leukaemia, multiple sclerosis, and rheumatoid arthritis, show a high incidence rate in North America. The apheresis process is crucial in the treatment of these diseases. Key industry players as well as favourable reimbursement policies in the United States further boost market growth in North America, making this the region with the greatest position.

Asia-Pacific however is poised to account for the greatest share of growth in the apheresis equipment market. The growth in this region can be attributed to the rising prevalence of chronic diseases, growing healthcare infrastructure, and increasing focus on healthcare access in developing countries. With regard to countries like China, India, and Japan, investment in better healthcare facilities and adoption of advanced medical technologies is making apheresis equipment accessible across varied healthcare settings. The growing awareness of therapeutic apheresis applications and the availability of specialized treatments are driving demand. Large, elderly populations that are prone to chronic diseases characterize the Asia-Pacific region, and it is expected to grow rapidly in the apheresis equipment market going forward.

List of Companies Profiled

• Asahi Kasei Medical Co., Ltd.
• Terumo BCT, Inc. (a Part of Terumo Corporation)
• Haemonetics Corporation
• Fresenius Kabi AG
• Braun SE
• Mallinckrodt Plc
• Nikkiso Europe GmbH (a Part of NIKKISO Group)

Key Industry Developments

In December 2023, TERUMO BCT, INC. participated in the second episode of the Connecting the Dot video series designed for the European-based MedTech industry.

In August 2023, TERUMO BCT, INC. received approval from the US FDA of a novel platelet device, which converts blood into platelets in just one cycle of centrifugation.

In August 2023, Lupagen Inc. and Fresenius Kabi AG entered into a supply and development agreement regarding technologies developed to bring gene and cell therapies to patients' bedsides.

Report Coverage

The report will cover the qualitative and quantitative data on the Global Apheresis Equipment Market. The qualitative data includes latest trends, market players’ analysis, market drivers, market opportunity, and many others. Also, the report quantitative data includes market size for every region, country, and segments according to your requirements. We can also provide customize report in every industry vertical.

Report Scope and Segmentations

Regional Analysis

North America accounted for the highest xx% market share in terms of revenue in the Apheresis Equipment market and is expected to expand at a CAGR of xx% during the forecast period. This growth can be attributed to the growing adoption of Apheresis Equipment. The market in APAC is expected to witness significant growth and is expected to register a CAGR of xx% over upcoming years, because of the presence of key Apheresis Equipment companies in economies such as Japan and China.

The objective of the report is to present comprehensive analysis of Global Apheresis Equipment Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.

Apheresis Equipment Market Report is also available for below Regions and Country Please Ask for that

North America

• U.S
• Canada

Europe

• Switzerland
• Belgium
• Germany
• France
• U.K
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Rest of Europe

Asia-Pacific

• India
• Australia
• Philippines
• Singapore
• South Korea
• Japan
• China
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Argentina
• Peru
• Colombia
• Brazil
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Points Covered in the Report

• The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
• The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analysed 5 years data history and forecast.
• The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.
• Data and information by market player, by region, by type, by application and etc., and custom research can be added according to specific requirements.
• The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Questions

• How much the global Apheresis Equipment Market valued?
• Which region has the largest share in 2024 for the global Apheresis Equipment Market?
• What are the driving factors for the market?
• Which is the leading segment in the global market?
• What are the major players in the market?

Research Scope of the Market

• Historic year: 2019-2022
• Base year: 2023
• Forecast: 2024 to 2032
• Representation of Market revenue in USD Million

Apheresis Equipment Market Trends: Market key trends which include Increased Competition and Continuous Innovations Trends: